发明名称 |
Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy |
摘要 |
The present invention provides a compound of formula I;;
or a pharmaceutically acceptable salt thereof, wherein X is defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention. |
申请公布号 |
US9102635(B2) |
申请公布日期 |
2015.08.11 |
申请号 |
US201414178312 |
申请日期 |
2014.02.12 |
申请人 |
NOVARTIS AG |
发明人 |
Barnes David Weninger;Rigel Dean Franklin |
分类号 |
C07D271/113;A61K31/4245;A61K45/06 |
主分类号 |
C07D271/113 |
代理机构 |
Sophie Binet Cross |
代理人 |
Sophie Binet Cross |
主权项 |
1. A compound of the formula (I):wherein:
X is OH, O—C1-7alkyl or O—C6-10aryl; or a pharmaceutically acceptable salt thereof. |
地址 |
Basel CH |